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Brief Research Report
Bluetongue virus (BTV; family Reoviridae, subfamily 
Sedoreovirinae, genus Orbivirus) is the causative agent of 
the arthropod-transmitted disease bluetongue, an economi-
cally important disease that affects a wide range of domestic 
and wild ruminants.10 Bluetongue can be especially severe 
among certain breeds of sheep with mortality reaching 30% 
or higher in some instances, whereas only subclinical infec-
tions typically occur in goats and cattle.10 To date, 26 distinct 
serotypes of BTV are recognized worldwide, and virulence 
is not determined by serotype alone.2 Variation in disease 
severity reflects differences in virulence among specific viral 
strains, as well as host, vector, and environmental factors.10 
Generally BTV is not contagious, rather it is transmitted to 
ruminants principally by biting midges of the genus Culicoi-
des.9 Distribution of different BTV serotypes and strains 
may be influenced by the presence of distinct competent vec-
tor Culicoides species and is dependent on specific climatic 
and environmental conditions.16-18
Since the initial recognition of BTV in North America 
around 1950, ongoing surveillance has identified only BTV 
serotypes 10, 11, 13, and 17 to be present throughout central 
and western regions of the United States.5,11,13 In contrast, 
numerous other BTV serotypes (including serotypes 1–6, 
9–14, 17, 19, 22, and 24) have been identified in the south-
eastern United States and Caribbean islands.5,9,17 Importantly, 
BTV serotype 2 (BTV-2) was identified in a dairy heifer 
from the northern Sacramento Valley of California,12,13 the 
first detection of this virus serotype in the western part of the 
United States since the initial isolation from cattle in Florida 
in 1982.3,6,7 The genome of this BTV-2 isolate from Califor-
nia (BTV-2 USA2010/CA) was subsequently sequenced, 
and initial BLAST analysis (http://www.ncbi.nlm.nih.gov/
blast/Blast.cgi) suggested that the virus may be a reassortant 
that is most related to the strains BTV-2 USA1999/FL and 
BTV-6 USA2006 isolated from Florida and the southeastern 
United States, respectively.12 To further characterize the 
BTV-2 USA2010/CA isolate, the current study compiled a 
database of complete BTV genome sequences available 
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Abstract. Bluetongue is a potentially fatal arboviral disease of domestic and wild ruminants that is characterized by 
widespread edema and tissue necrosis. Bluetongue virus (BTV) serotypes 10, 11, 13, and 17 occur throughout much of the 
United States, whereas serotype 2 (BTV-2) was previously only detected in the southeastern United States. Since 1998, 10 
other BTV serotypes have also been isolated from ruminants in the southeastern United States. In 2010, BTV-2 was identified 
in California for the first time, and preliminary sequence analysis indicated that the virus isolate was closely related to BTV 
strains circulating in the southeastern United States. In the current study, the whole genome sequence of the California strain 
of BTV-2 was compared with those of other BTV-2 strains in the Americas. The results of the analysis suggest co-circulation 
of genetically distinct viruses in the southeastern United States, and further suggest that the 2010 western isolate is closely 
related to southeastern strains of BTV. Although it remains uncertain as to how this novel virus was translocated to California, 
the findings of the current study underscore the need for ongoing surveillance of this economically important livestock disease.
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from GenBank as well as additional previously unpublished 
sequences of 3 BTV isolates from the United States and Pan-
ama (Table 1). Alignments and phylogenetic analysis were 
then performed to better understand the relationships of these 
BTV strains and the putative origin of this particular BTV-2 
strain isolated from California.
Virus strains were propagated in baby hamster kidney 
(CCL 10)a or bovine pulmonary artery endothelial (CCL 
209)a cells, and viral double-stranded RNA (dsRNA) puri-
fied from extracted total RNA by a previously described 
method.19 A whole genome sequence-independent amplifi-
cation procedure was performed as previously described.15 
Briefly, restriction sites were removed from the anchor 
primer PC3-T7restrict (5′p-GTTCAGCCTGACCACGTTAA 
TACGACTCACTATATTTTTATAGTGAGTCGTATT 
A-OH3′), to facilitate sequencing and then purified by 
high-performance liquid chromatography. The PC3-
T7restrict primer (600 ng) was ligated to dsRNA (500 ng) in 
the ligation reaction mix as described previously15 for a final 
volume of 90 μl. Ligation was performed at 37°C for 16 hr, 
and then purified using a commercial kitb following the pro-
tocol recommended by the manufacturer. The cleaned and 
ligated product (8 μl) was supplemented with 25 pmol 
PC2restrict primer (5′p-ACGTGGTCAGGCTGAAC-3′) 
and 1 μl of 300 mM methyl mercury hydroxide and allowed 
to denature for 10 min, The mixture was placed on ice, and 
1.5 μl of 1 M β-mercaptoethanol was added and allowed to 
neutralize for 1 min. The copy DNA (cDNA) was then gen-
erated using cloned Avian myeloblastosis virus reverse 
transcriptase,c annealed at 65°C for 90 min, and the remain-
ing products neutralized as described previously.15 Amplifi-
cation of cDNA was performed using 25 pmol of PC2restrict 
primer and Taq enzyme.d  Amplification products were con-
firmed by agarose gel electrophoresis and purified using a 
commercially available kit.b
Library preparation and sequencing was performed using 
a commercial platforme with the corresponding commer-
cially available kits,f following the protocols recommended 
by the manufacturer. Briefly, approximately 1 μg of viral 
cDNA was fragmented, barcoded, and quantitated.f Tem-
plate generation, enrichment, and sequencing of the template 
were performed on the appropriate instruments.e
Standard flowgram format files were imported to com-
mercial softwareg for contig creation. Partial contigs were 
assembled and blasted to determine reference sequences that 
were then used for reference assemblies. Multiple sequence 
alignments of the nucleotide sequences were performed 
using the multiple alignment fast Fourier transform method 
followed by in silico translation of the open reading frames 
and alignment of the predicted proteins for each genomic 
segment. Distance relationships were calculated from the 
nucleotide and protein alignments. Although a comprehen-
sive analysis was performed with all full-length gene 
sequences available from GenBank, for simplicity, only the 
most relevant, closely related strains and U.S. prototype 
BTV strains are shown (Table 2).
Overall, the California isolate shared the highest identity 
with BTV-2 USA1982/OnaB (Table 2). Seven of the 10 
BTV genome segments (M4-S10) share 98% or greater 
sequence identity with the OnaB strain, and 5 of these 7 
share 100% identity with the predicted proteins (Table 2). 
Segments L2 and L3 were more closely related to BTV-2 
USA2006/FL and BTV-2 USA2003/FL, respectively 
(Table 2). The L1 gene and encoded VP1 protein was most 
conserved with BTV-6 USA2006 isolated from the south-
eastern United States (Table 2). Thus, results from the analy-
sis indicate that the BTV-2 USA2010/CA isolate is most 
closely related to BTV-2 strains from the southeastern United 
States and Florida region. The BTV-2 PAN1990 isolate 
shared close identity to the BTV-2 strains analyzed, yet 
branched distinctly from both the Republic of South Africa 
(RSA) prototype and U.S. strains (trees not shown).
The first identification of BTV-2 in the United States was 
in 1982.3,6,7 At that time, two BTV-2 isolates with distinct 
RNA electrophoretic mobilities were identified from the 
town of Ona, Florida and designated as OnaA and OnaB.14 
The OnaA strain was the first isolated, and was identical to 
the South African BTV-2 prototype.14 However, after the ini-
tial isolation in September and October of 1982, there were 
no further isolations of the OnaA strain. The Ona B strain 
was isolated at the same site in October and November of 
1982.14 Electrophoretic mobility changes were identified in 
multiple genome segments, and subsequent sequencing con-
firmed mutations in genes encoding VP7, NS1, and NS2.14 
Additional isolations of OnaB were made in Florida and later 
in Alabama through 1985.3,4 However, BTV-2 was not iden-
tified again in the United States until 1999 when it was iso-
lated from sheep in Florida.14 When compared to the original 
1982 isolates, the 1999 BTV-2 isolate most resembled OnaB, 
suggesting that OnaB had persisted in the region.14 The 
Table 1. Newly sequenced Bluetongue virus (BTV) strains included in the current study with the corresponding accession numbers.
Virus strain name Origin Year Accession numbers
BTV-2 USA2003/FL Florida, USA 2003 KF986512, KF986499, KF986500, KF986506, KF986502, KF986517, 
KF986509, KF986510, KF986513, KF986511
BTV-2 USA2006/FL Florida, USA 2006 KF986496, KF986495, KF986488, KF986492, KF986514, KF986490, 
KF986505, KF986508, KF986504, KF986498
BTV-2 PAN1990 Panama 1990 KF986497, KF986501, KF986489, KF986515, KF986493, KF986494, 
KF986503, KF986516, KF986507, KF986491
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OnaB strain was found to be closely related genetically to 2 
other BTV strains of other serotypes circulating in Florida at 
the same time, specifically BTV-13 (AY855268) and BTV-
17 (AY855269), indicating that this virus had reassorted 
with other BTV serotypes in the area.14 Collectively, the 
findings from these previous studies suggest that BTV-2 was 
perhaps first introduced to the United States in 1982 and cir-
culated for a short period of time as the original OnaA strain 
before quickly diverging genetically to the OnaB strain, and 
eventually reassorting with other BTV strains circulating in 
the region.
The California BTV-2 USA2010/CA isolate was identi-
fied in the blood of a heifer during an epidemiological sur-
veillance study of 4 dairy farms in northern Sacramento 
Valley that took place in 2010.12,13 This finding was novel 
because it represents a documented instance of BTV-2 being 
detected in a region of the United States beyond the south-
east.12 There is, to date, no approved vaccine for BTV-2 in 
the United States. Although some of the animals from the 
surveillance study suffered from ulcerative stomatitis and 
coronitis, other BTV serotypes were also present on the farm 
concurrently, making any association of disease with this 
particular strain of BTV-2 speculative and its clinical sig-
nificance uncertain.12,13 Unfortunately, although the heifer 
was apparently born on the farm in California, there was no 
detailed history available regarding movement of other live-
stock onto the premises. Without comprehensive ongoing 
surveillance, and only limited data available, it remains 
unclear how this novel strain of BTV-2 was introduced to 
California. The current phylogenetic analysis showed that 
the BTV-2 USA2010/CA isolate, as well as BTV strains 
from the southeastern United States, grouped distinctly from 
the BTV-2 RSA prototype and the original USA1982/OnaA 
strain. This suggests that the BTV-2 USA2010/CA isolate is 
closely related to more recent circulating BTV-2 strains from 
the southeastern United States.
Bluetongue virus strains are known to undergo rapid 
genetic mutations and freely reassort with other BTV 
strains regardless of serotype, thus contributing to the vast 
diversity of BTV strains in the field.1,2,8 It is unknown 
which gene(s) confers virulence, and field strains of the 
same serotype can differ greatly in terms of both their 
sequence and severity of disease they cause.2 Overall, the 
current analysis showed BTV-2 USA2010/CA shared high 
identity with several strains of BTV-2 as well as other sero-
types (BTV-13 USA1999/FL, BTV-17 USA1999/FL, and 
BTV-6 USA2006) originating in the southeastern United 
States, but not with BTV strains circulating in the western 
United States. Furthermore, BTV-2 has not been detected 
previously in western North America despite ongoing sur-
veillance in the region.11,13 Considering the genetic rela-
tionship reported herein and the fact that no additional 
BTV-2 isolates have been made, it appears that this BTV-2 
isolate is, most likely, uncommon and only recently intro-
duced to California. The isolation of a novel BTV serotype 
in the western United States, along with the incursion of 
BTV into new territories worldwide9,16 warrants attention 
and further underscores the need for ongoing entomologic 
and livestock surveillance.
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